RNS Number : 1203W
Legal & General UCITS ETF PLC
14 August 2020
| Funds |
Date |
ISIN code |
Shares in Issue |
Currency |
Net Asset Value |
NAV/per share Base |
| L&G US Equity UCITS ETF |
13/08/2020 |
IE00BFXR5Q31 |
12907267 |
USD |
164558245.79 |
12.749 |
| L&G UK Equity UCITS ETF |
13/08/2020 |
IE00BFXR5R48 |
1200000 |
GBP |
11021373.83 |
9.184 |
| L&G Global Equity UCITS ETF |
13/08/2020 |
IE00BFXR5S54 |
2900000 |
USD |
35394686.60 |
12.205 |
| L&G Japan Equity UCITS ETF |
13/08/2020 |
IE00BFXR5T61 |
11185000 |
USD |
122775409.34 |
10.977 |
| L&G Europe ex UK Equity UCITS ETF |
13/08/2020 |
IE00BFXR5V83 |
9360988 |
EUR |
103877920.74 |
11.097 |
| L&G Asia Pacific ex Japan Equity UCITS ETF |
13/08/2020 |
IE00BFXR5W90 |
5281427 |
USD |
57587506.79 |
10.904 |
| L&G Clean Water UCITS ETF |
13/08/2020 |
IE00BK5BC891 |
1500000 |
USD |
17391439.07 |
11.594 |
| L&G Artificial Intelligence UCITS ETF |
13/08/2020 |
IE00BK5BCD43 |
7946000 |
USD |
109634844.30 |
13.797 |
| L&G Healthcare Innovation UCITS ETF |
13/08/2020 |
IE00BK5BC677 |
3000000 |
USD |
42073317.17 |
14.024 |
| L&G Pharma Breakthrough UCITS ETF |
13/08/2020 |
IE00BF0H7608 |
2000000 |
USD |
24743840.25 |
12.372 |
| L&G Europe Equity (Responsible Exclusions) UCITS ETF |
13/08/2020 |
IE00BKLTRN76 |
9600000 |
EUR |
100612151.67 |
10.480 |
| L&G US Equity (Responsible Exclusions) UCITS ETF |
13/08/2020 |
IE00BKLWY790 |
57800000 |
USD |
664453150.67 |
11.496 |
| L&G Battery Value-Chain UCITS ETF |
13/08/2020 |
IE00BF0M2Z96 |
14250000 |
USD |
156321065.09 |
10.970 |
| L&G Ecommerce Logistics UCITS ETF |
13/08/2020 |
IE00BF0M6N54 |
9650000 |
USD |
116691142.18 |
12.092 |
| L&G ROBO Global Robotics and Automation UCITS ETF |
13/08/2020 |
IE00BMW3QX54 |
46630616 |
USD |
886182716.19 |
19.004 |
| L&G Cyber Security UCITS ETF |
13/08/2020 |
IE00BYPLS672 |
83781776 |
USD |
1665655923.97 |
19.881 |
|
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
[email protected] or visit
www.rns.com.
END
NAVDZGMRZFFGGZZ
